Study of an experimental drug for moderate to severe COPD
Treatments studied
Part of Lungs & breathing clinical trials.
This study tests an experimental drug for people with moderate to severe COPD, especially those with chronic bronchitis. It aims to see how the drug affects certain markers in your body and whether it helps with your COPD symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years or older.
- You have had a COPD diagnosis for at least 12 months.
- Your COPD is moderate to severe but not extremely severe.
- You have had a chronic cough with mucus for a while (chronic bronchitis).
- You must be on regular COPD maintenance inhalers for at least 6 months before the trial, and your dose must stay the same during the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an inhaled medication for COPD. It aims to see if the treatment is safe and helps improve breathing and symptoms.
This study tests whether a new inhaled medication called HSK39004 can help people with COPD breathe better and reduce shortness of breath. You'll receive either the medication or a placebo (inactive powder) and be monitored for safety and effectiveness.
This study tests an experimental medicine called R-3750 to see if it is safe and helpful for people with mild to moderate COPD. It is an early-phase trial, so the main goal is safety, but they will also look at how your breathing responds.
This study tests an inhaled medication called RB042 in healthy adults, healthy smokers, and people with COPD. It aims to see how the drug works in the body and whether it is safe, which could help in developing a new treatment for COPD.
This trial tests an investigational tablet for people with chronic lung diseases like bronchiectasis, COPD, or asthma who produce at least 10 mL of sputum (mucus coughed up from the lungs) each day. The goal is to see if the drug safely reduces excess airway mucus.
This trial tests a new medicine called CM326 for people with moderate to severe COPD. It aims to see if the drug can reduce flare-ups and improve lung function.
Hear when a new COPD (Chronic Obstructive Pulmonary Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.